BDX Q4 2022 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.8B-7.3% YoY

Gross Profit

$2.1B43.6% margin

Operating Income

$489M10.3% margin

Net Income

$288M6.0% margin

EPS (Diluted)

$0.92

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

$971M

Free Cash Flow

$656M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$52.9B

Total Liabilities

$27.7B

Stockholders' Equity

$25.3B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.8B	$5.1B	-7.3%
Gross Profit	$2.1B	$2.3B	-9.2%
Operating Income	$489M	$495M	-1.2%
Net Income	$288M	$265M	+8.7%

Revenue Segments

Medical

$1.8B44%

Life Sciences

$1.3B30%

Interventional

$1.1B26%

Geographic Segments

UNITED STATES

$2.4B57%

Non-US

$1.8B43%